Literature DB >> 18982431

Immunochemical composition of cryoglobulins generated in stroke.

Levon Manukyan1, Anna Boyajyan, Arsen Arakelyan, Violetta Ayvazyan, Elina Arakelova, Robert Sim, George Grigoryan.   

Abstract

INTRODUCTION: Cryoglobulins are abnormal immune complexes where both the antigens and the antibodies are immunoglobulins. The ability of cryoglobulins to bind C-reactive protein and low density lipoproteins, activate complement, and stimulate production of tumor necrosis factor-alpha generates interest in studying cryoglobulins in ischemic stroke.
MATERIALS AND METHODS: We determined blood levels of cryoglobulins in patients with ischemic stroke at different time points of stroke onset and identified the composition of cryoglobulins isolated from the blood on the first day of stroke onset.
RESULTS: On days 1-14, significantly elevated levels of cryoglobulins were detected with the maximum level on day 3. DISCUSSION: Determination of immunoglobulin (Ig) content of cryoglobulins revealed the presence of a mixture of polyclonal IgG, IgA, and IgM, C3 complement protein and its activation split products, C1q complement protein, pathogenic lipoprotein-X, and beta-lipoprotein.
CONCLUSION: We suggest that cryoglobulins are involved in post-ischemic inflammatory response through activation of the complement cascade and cytokines production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982431     DOI: 10.1007/s10875-008-9257-5

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  37 in total

1.  Cryoglobulin-induced cytokine production via FcgammaRIIa: inverse effects of complement blockade on the production of TNF-alpha and IL-10. Implications for the growth of malignant B-cell clones.

Authors:  Linda Mathsson; Andreas Tejde; Kristina Carlson; Martin Höglund; Bo Nilsson; Kristina Nilsson-Ekdahl; Johan Rönnelid
Journal:  Br J Haematol       Date:  2005-06       Impact factor: 6.998

2.  Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B.

Authors:  E G Lynn; Y L Siow; J Frohlich; G T Cheung; K O
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

Review 3.  Complement factor I and cofactors in control of complement system convertase enzymes.

Authors:  R B Sim; A J Day; B E Moffatt; M Fontaine
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

4.  Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification.

Authors:  C E Jahn; E J Schaefer; L A Taam; J H Hoofnagle; F T Lindgren; J J Albers; E A Jones; H B Brewer
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

5.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

6.  Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis.

Authors:  M Yepes; M Sandkvist; M K Wong; T A Coleman; E Smith; S L Cohan; D A Lawrence
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

Review 7.  Acute stroke: pathophysiology, diagnosis, and treatment.

Authors:  Joan Parker Frizzell
Journal:  AACN Clin Issues       Date:  2005 Oct-Dec

8.  Cryoglobulins as indicators of upregulated immune response in schizophrenia.

Authors:  Anna Boyajyan; Aren Khoyetsyan; Gohar Tsakanova; Robert B Sim
Journal:  Clin Biochem       Date:  2007-12-04       Impact factor: 3.281

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7.

Authors:  Inna Verbovetski; Hila Bychkov; Uriel Trahtemberg; Itzhak Shapira; Mara Hareuveni; Ofira Ben-Tal; Ina Kutikov; Oranit Gill; Dror Mevorach
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.